Literature DB >> 24355926

CotH3 mediates fungal invasion of host cells during mucormycosis.

Teclegiorgis Gebremariam, Mingfu Liu, Guanpingsheng Luo, Vincent Bruno, Quynh T Phan, Alan J Waring, John E Edwards, Scott G Filler, Michael R Yeaman, Ashraf S Ibrahim.   

Abstract

Angioinvasion is a hallmark of mucormycosis. Previously, we identified endothelial cell glucose-regulated protein 78 (GRP78) as a receptor for Mucorales that mediates host cell invasion. Here we determined that spore coat protein homologs (CotH) of Mucorales act as fungal ligands for GRP78. CotH proteins were widely present in Mucorales and absent from noninvasive pathogens. Heterologous expression of CotH3 and CotH2 in Saccharomyces cerevisiae conferred the ability to invade host cells via binding to GRP78. Homology modeling and computational docking studies indicated structurally compatible interactions between GRP78 and both CotH3 and CotH2. A mutant of Rhizopus oryzae, the most common cause of mucormycosis, with reduced CotH expression was impaired for invading and damaging endothelial cells and CHO cells overexpressing GRP78. This strain also exhibited reduced virulence in a diabetic ketoacidotic (DKA) mouse model of mucormycosis. Treatment with anti-CotH Abs abolished the ability of R. oryzae to invade host cells and protected DKA mice from mucormycosis. The presence of CotH in Mucorales explained the specific susceptibility of DKA patients, who have increased GRP78 levels, to mucormycosis. Together, these data indicate that CotH3 and CotH2 function as invasins that interact with host cell GRP78 to mediate pathogenic host-cell interactions and identify CotH as a promising therapeutic target for mucormycosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24355926      PMCID: PMC3871245          DOI: 10.1172/JCI71349

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Mucormycosis in hematologic malignancies: an emerging fungal infection.

Authors:  A Nosari; P Oreste; M Montillo; G Carrafiello; M Draisci; G Muti; A Molteni; E Morra
Journal:  Haematologica       Date:  2000-10       Impact factor: 9.941

2.  The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.

Authors:  Brad Spellberg; Ashraf S Ibrahim; Peter V Chin-Hong; Dimitrios P Kontoyiannis; Michele I Morris; John R Perfect; David Fredricks; Eric P Brass
Journal:  J Antimicrob Chemother       Date:  2011-09-20       Impact factor: 5.790

3.  Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.

Authors:  Guanpingsheng Luo; Teclegiorgis Gebremariam; Hongkyu Lee; Samuel W French; Nathan P Wiederhold; Thomas F Patterson; Scott G Filler; Ashraf S Ibrahim
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

Review 4.  Pathogenesis of mucormycosis.

Authors:  Ashraf S Ibrahim; Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

Review 5.  Epidemiology and clinical manifestations of mucormycosis.

Authors:  George Petrikkos; Anna Skiada; Olivier Lortholary; Emmanuel Roilides; Thomas J Walsh; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

6.  Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis).

Authors:  Thomas J Walsh; Maria N Gamaletsou; Michael R McGinnis; Randall T Hayden; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

Review 7.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

8.  Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway.

Authors:  Yue Fu; Ashraf S Ibrahim; Donald C Sheppard; Yee-Chun Chen; Samuel W French; Jim E Cutler; Scott G Filler; John E Edwards
Journal:  Mol Microbiol       Date:  2002-04       Impact factor: 3.501

9.  Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011.

Authors:  Robyn Neblett Fanfair; Kaitlin Benedict; John Bos; Sarah D Bennett; Yi-Chun Lo; Tolu Adebanjo; Kizee Etienne; Eszter Deak; Gordana Derado; Wun-Ju Shieh; Clifton Drew; Sherif Zaki; David Sugerman; Lalitha Gade; Elizabeth H Thompson; Deanna A Sutton; David M Engelthaler; James M Schupp; Mary E Brandt; Julie R Harris; Shawn R Lockhart; George Turabelidze; Benjamin J Park
Journal:  N Engl J Med       Date:  2012-12-06       Impact factor: 91.245

10.  A non-fatal case of invasive zygomycete (Lichtheimia corymbifera) infection in an allogeneic haematopoietic cell transplant recipient.

Authors:  Steffen Eickhardt; Peter Braendstrup; Erik Clasen-Linde; Karl E Jensen; Morten Alhede; Thomas Bjarnsholt; Niels Høiby; Lars Vindeløv; Claus Moser
Journal:  APMIS       Date:  2012-11-23       Impact factor: 3.205

View more
  78 in total

Review 1.  The spectrum of fungi that infects humans.

Authors:  Julia R Köhler; Arturo Casadevall; John Perfect
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Adaptation to thermotolerance in Rhizopus coincides with virulence as revealed by avian and invertebrate infection models, phylogeny, physiological and metabolic flexibility.

Authors:  Kerstin Kaerger; Volker U Schwartze; Somayeh Dolatabadi; Ildikó Nyilasi; Stella A Kovács; Ulrike Binder; Tamás Papp; Sybren de Hoog; Ilse D Jacobsen; Kerstin Voigt
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 3.  Host cell invasion by medically important fungi.

Authors:  Donald C Sheppard; Scott G Filler
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

4.  Mucormycosis pathogenesis: Beyond Rhizopus.

Authors:  Brad Spellberg
Journal:  Virulence       Date:  2017-08-25       Impact factor: 5.882

5.  PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis.

Authors:  Clara Baldin; Sameh S M Soliman; Heewon H Jeon; Sondus Alkhazraji; Teclegiorgis Gebremariam; Yiyou Gu; Vincent M Bruno; Oliver A Cornely; Helen L Leather; Michele W Sugrue; John R Wingard; David A Stevens; John E Edwards; Ashraf S Ibrahim
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

6.  Ketoacidosis alone does not predispose to mucormycosis by Lichtheimia in a murine pulmonary infection model.

Authors:  Bianca Schulze; Günter Rambach; Volker U Schwartze; Kerstin Voigt; Katja Schubert; Cornelia Speth; Ilse D Jacobsen
Journal:  Virulence       Date:  2017-08-24       Impact factor: 5.882

7.  Hostile takeover: fungal protein promotes host cell invasion.

Authors:  J Andrew Alspaugh
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

Review 8.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

9.  In Situ Validation of the Endothelial Cell Receptor GRP78 in a Case of Rhinocerebral Mucormycosis.

Authors:  Evgenii Shumilov; Ulrike Bacher; Christina Perske; Alexander Mohr; Helmut Eiffert; Justin Hasenkamp; Lorenz Trümper; Gerald G Wulf; Philipp Ströbel; Ashraf S Ibrahim; Vivek Venkataramani
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

10.  Heat-killed yeast protects diabetic ketoacidotic-steroid treated mice from pulmonary mucormycosis.

Authors:  Guanpingsheng Luo; Teclegiorgis Gebremariam; Karl V Clemons; David A Stevens; Ashraf S Ibrahim
Journal:  Vaccine       Date:  2014-05-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.